FATP1-IN-2 is primarily utilized in research focused on metabolic disorders and lipid metabolism. It acts as an inhibitor of Fatty Acid Transport Protein 1 (FATP1), which plays a critical role in the cellular uptake of long-chain fatty acids. By inhibiting FATP1, this compound helps scientists study the mechanisms underlying conditions such as obesity, diabetes, and insulin resistance. It is also used to explore potential therapeutic strategies targeting lipid metabolism and energy homeostasis. Additionally, FATP1-IN-2 serves as a tool to investigate the role of fatty acid transport in various cellular processes, including inflammation and cancer progression. Its application extends to preclinical studies aimed at developing treatments for metabolic diseases.